Illumina Inc

ILMN 
(NASDAQ) 
 
$ 319.03 <%= Resources.Global.txtUp %>
Updated 17/04/2019
Change % 0.11% Stock price increasing
Change 0.34 Stock price increasing
Volume 815,136
High $ 323.46
Low $ 312.50
Open $ 321.77
ISIN
Prev close $ 318.69
# of shares 146.93M
Market cap 46,874M USD
Intraday

Market closed
Illumina Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  319.03 -5.7% Stock price decreasing -0.1% Stock price decreasing 2.0% Stock price increasing 1.9% Stock price increasing 30.4% Stock price increasing
Powered by TradingView

News about Illumina Inc

  • English
  • Regulatory news

Company profile

Illumina is a major player in life science tools for analyzing genetic material. Revenue from microarray and genome sequencing machines and disposables make up most of the company's revenue, but approximately 18% of the company's sales come from testing services. Essentially all of Illumina's growth stems from the company's genome sequencing products, which include the company's high-throughput NovaSeq and HiSeq instruments in addition to its benchtop NextSeq, MiSeq, and MiniSeq, and iSeq product lines.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2019 09:54:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB2 - 2019-04-21 10:54:40 - 2019-04-21 09:54:40 - 1000 - Website: OKAY